Purchases and Sales Made in Q4 2022 in Diffusion Pharmaceuticals Inc. (DFFN)
This table provides information about the institutional ownership of Diffusion Pharmaceuticals Inc. (DFFN) during Q4 2022. The information is specifically focused on institutions that hold shares of Diffusion Pharmaceuticals Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
810+ 40.54% |
$3.76K - $5.28K
|
2.81K
$26K
|
|
Feb 10, 2023
Q4 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
42+ 0.06% |
$195 - $274
|
72.8K
$673K
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
4New |
$18.6 - $26.1
|
4
$37
|
|
May 16, 2024
Q4 2022
|
Connective Capital Management, LLC
Palo Alto, CA |
BUY
|
- |
1New |
$4.64 - $6.52
|
1
$9.25
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Feb 13, 2023
Q4 2022
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-42- 0.24% |
$195 - $274
|
17.1K
$158K
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
SELL
|
- |
-533- 62.27% |
$2.47K - $3.48K
|
323
$2.99K
|
|
Feb 13, 2023
Q4 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-5.2K- 11.82% |
$24.1K - $33.9K
|
38.8K
$359K
|